QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats

CONTEXT: Atorvastatin (ATV) and QiShenYiQi pills (QSYQ), a Chinese patent medicine, are often co-prescribed to Chinese cardiovascular patients. The effects of QSYQ on the pharmacokinetics of ATV have not been studied. OBJECTIVE: We investigated the influence of QSYQ on the pharmacokinetics of ATV an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Congyang, Li, Yajing, Li, Xiao, Meng, Lu, Fu, Ran, Wang, Xiaonan, Li, Ying, Ma, Yinling, Dong, Zhanjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745373/
https://www.ncbi.nlm.nih.gov/pubmed/35001796
http://dx.doi.org/10.1080/13880209.2021.2021949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745373/
https://www.ncbi.nlm.nih.gov/pubmed/35001796
http://dx.doi.org/10.1080/13880209.2021.2021949

Ejemplares similares